Knowlexaconnect Knowlexaconnect
Suchergebnisse
Alle Ergebnisse anzeigen
  • Beitreten
    Anmelden
    Registrieren
    Suche
    Nachtmodus

Suche

Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften

  • Newsfeed
  • ERKUNDEN
  • Seiten
  • Gruppen
  • Veranstaltungen
  • Reels
  • Blogs
  • Angebote
  • Jobs
  • Beiträge
  • Blogs
  • User
  • Seiten
  • Gruppen
  • Veranstaltungen
  • Vandana Manturgekar hat ein neuen Blog hinzugefügt Startseite
    2026-01-09 07:22:44 -
    Biomarkers For Signing Cancer Market Revenue, Trends, Analysis, Demand and Forecast to 2032
    The Biomarkers For Signing Cancer Market was valued at USD 5.2 billion in 2024 and is projected to reach USD 12.8 billion by 2034, registering a CAGR of 9.2%. This growth trajectory is underpinned by several factors, including the increasing prevalence of cancer globally, advancements in biomarker research, and the rising demand for personalized medicine. The growing emphasis on early detection...
    0 Kommentare 0 Geteilt 221 Ansichten 0 Bewertungen
    Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
  • Isha Deshpande hat ein neuen Blog hinzugefügt Andere
    2026-01-09 07:33:59 -
    Executive Brief: Competitive Landscape and Strategic Developments in the Advanced Pancreatic Cancer Market
    The Advanced Pancreatic Cancer Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 7.2 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including the rising incidence of pancreatic cancer, advancements in treatment modalities, and increasing awareness regarding early diagnosis and treatment options. The global...
    0 Kommentare 0 Geteilt 109 Ansichten 0 Bewertungen
    Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
  • Deng Yue hat ein neuen Blog hinzugefügt Health
    2026-01-30 09:21:22 -
    Targeting the Cell Cycle to Safeguard Hope: The Clinical Value and Development of CDK4/6 Inhibitors
    Written by DengyuePharma As cancer treatment enters the era of precision medicine, the emergence of each novel targeted therapy has brought renewed hope to countless patients. CDK4/6 inhibitors, a class of targeted agents focusing on cell cycle regulation, have established a central role in the treatment of hormone receptor–positive (HR+), human epidermal growth factor receptor...
    0 Kommentare 0 Geteilt 79 Ansichten 0 Bewertungen
    Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
© 2026 Knowlexaconnect Deutsch
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Kontaktiere uns Verzeichnis